| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6198976 | Ophthalmology | 2016 | 9 Pages |
Abstract
Patients who have not yet “responded” to PRN ranibizumab seem to exhibit retinal dehydration after switching to aflibercept, whereas there was no demonstration of VA benefit. Baseline features at the point of switching can independently predict outcomes.
Keywords
PEDpigment epithelium detachmentVMTIRFnAMDintraretinal fluidPRNERMSRFAMDCStOctOptical coherence tomographyVisual acuityneovascular age-related macular degenerationage-related macular degenerationcentral subfield thicknesspro re nataepiretinal membraneconfidence intervalVascular endothelial growth factorVascular Endothelial Growth Factor (VEGF)outer retinal tubulationSubretinal fluidORTvitreomacular traction
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Irini MD, PhD, Luke FRCOphth, Eleni MD, Chysoula MBBS, Deepthy MBBS, Theodoros N. MD, Maria Cristina BSC, Robin FRCOphth, Praveen J. FRCOphth, Phil FRCOphth, Sobha FRCOphth,